The cell biology of thrombospondin-1

Matrix Biology

Volumn 19, Issue 7, 2000, Pages 597-614

  Chen, Hui ^a   Herndon, Mary E ^a   Lawler, Jack ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Angiogenesis; CD36; Glycosaminoglycan; Integrin; Integrin associated protein; Proteoglycan; Thrombospondin; Transforming growth factor (TGF )

Indexed keywords

CD36 ANTIGEN; CD47 ANTIGEN; CYTOKINE; GLYCOSAMINOGLYCAN; GROWTH FACTOR; INTEGRIN; INTEGRIN RECEPTOR; MATRICELLULAR PROTEIN; MEMBRANE RECEPTOR; PROTEINASE; PROTEOGLYCAN; SCLEROPROTEIN; THROMBOSPONDIN 1; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANGIOGENESIS; BINDING SITE; CELL ADHESION; CYTOLOGY; EXTRACELLULAR MATRIX; HUMAN; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN STRUCTURE, FUNCTION AND VARIABILITY; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; TISSUE REPAIR;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, CD36; CYTOSKELETON; EXTRACELLULAR MATRIX PROTEINS; HUMANS; MOLECULAR SEQUENCE DATA; PROTEIN STRUCTURE, TERTIARY; SIGNAL TRANSDUCTION; THROMBOSPONDIN 1;

EID: 0033734494     PISSN: 0945053X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0945-053X(00)00107-4     Document Type: Short Survey

References (168)

1. Activation of platelet transforming growth factor beta-1 in the absence of thrombospondin-1
2. Diverse mechanisms for cell attachment to platelet thrombospondin
3. Cell-type specific adhesive interactions of skeletal myoblasts with thrombospondin-1
4. A novel class of murine semaphorins with homology to thrombospondin is differentially expressed during early embryogenesis
5. Muskelin, a novel intracellular mediator of cell adhesive and cytoskeletal responses to thrombospondin-1
6. Cell-matrix adhesions differentially regulate fascin phosphorylation
7. Formation of stable microspikes containing actin and the 55-kDa actin bundling protein, fascin, is a consequence of cell adhesion to thrombospondin-1: Implications for the anti-adhesive activities of thrombospondin-1
8. Characterization of cell-matrix adhesion requirements for the formation of fascin microspikes
9. CD47 ligation selectively downregulates human interleukin 12 production
10. Analysis of CD36 binding domains: Ligand specificity controlled by dephosphorylation of an ectodomain
11. Thrombospondin sequence motif (CSVTCG) is responsible for CD36 binding
12. Perlecan, basal lamina proteoglycan, promotes basic fibroblast growth factor-receptor binding, mitogenesis, and angiogenesis
13. Differential structural requirements of heparin and heparan sulfate proteoglycans that promote binding of basic fibroblast growth factor to its receptor
14. CD36 peptides that block cytoadherence define the CD36 binding region for Plasmodium falciparum-infected erythrocytes
15. Tumor suppression in human skin carcinoma cells by chromosome 15 transfer or thrombospondin-1 overexpression through halted tumor vasculature
16. Onset and progression of pathological lesions in transforming growth factor-beta 1-deficient mice
17. Thrombospondins: Structure and regulation of expression
18. Src-related protein tyrosine kinases are physically associated with the surface antigen CD36 in human dermal microvascular endothelial cells
19. Molecular mediators of angiogenesis in bladder cancer
20. Rapid clearance of malaria circumsporozoite protein (CS) by hepatocytes
21. Pro-adhesive and chemotactic activities of thrombospondin-1 for breast carcinoma cells are mediated by alpha3beta1 integrin and regulated by insulin-like growth factor-1 and CD98
22. Impaired memory retention and decreased long-term potentiation in integrin-associated protein-deficient mice
23. Properties of recombinant mouse thrombospondin-2 expressed in Spodoptera cells
24. Binding and degradation of thrombospondin-1 mediated through heparan sulfate proteoglycans and low-density-lipoprotein receptor-related protein: Localization of the functional activity to the trimeric N-terminal heparin-binding region of thrombospondin-1
25. Thrombspondin acts via integrin-associated protein to activate the platelet integrin alphaIIbbeta3
26. Thrombospondin-1 acts via IAP/CD47 to synergize with collagen in a2b1-mediated platelet activation
27. cDNA cloning and expression of bovine procollagen I N-proteinase: A new member of the superfamily of zinc-metalloproteinases with binding sites for cells and other matrix components
28. Tansendothelial migration of neutrophils involves integrin-associated protein (CD47)
29. Thrombospondin-1 is a major activator of TGF-b1 in vivo
30. Identification of a CD36-related thrombospondin 1-binding domain in HIV- 1 envelope glycoprotein gp120: Relationship to HIV-1-specific inhibitory factors in human saliva
31. Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1
32. Vascular biology of CD36: Roles of this new adhesion molecule family in different disease states
33. Thrombospondin as an inhibitor of angiogenesis
34. CD36 mediates the in vitro inhibitory effects of thrombospondin-1 on endothelial cells
35. Three distinct D-amino acid substitutions confer potent antiangiogenic activity on an inactive peptide derived from a thrombospondin-1 type 1 repeat
36. Identification of integrin α3β1 as a neuronal thrombospondin receptor mediating neurite outgrowth
37. Early-onset multifocal inflammation in the transforming growth factor beta 1-null mouse is lymphocyte-mediated
38. Angiogenic macrophages produce the angiogenic inhibitor thrombospondin 1
39. A monoclonal antibody against human thrombospondin inhibits platelet aggregation
40. Monoclonal antibodies that recognize calcium-dependent structures in human thrombospondin
41. Thrombin-stimulated calcium mobilization is inhibited by thrombospondin via CD36
42. The thrombospondin receptor integrin-associated protein (CD47) functionally couples to heterotrimeric Gi
43. Thrombospondins
44. Malaria circumsporozoite protein binds to heparan sulfate proteoglycans associated with the surface membrane of hepatocytes
45. Thrombospondin-1 regulation of smooth muscle cell chemotaxis extracellular signal-regulated protein kinases 1/2 dependent
46. Thrombospondin-1 induces activation of focal adhesion kinase in vascular smooth muscle cells
47. Mapping of epitopes for monoclonal antibodies against human platelet thrombospondin with electron microscopy and high sensitivity amino acid sequencing
48. Cell adhesion to a motif shared by the malaria circumsporozoite protein and thrombospondin is mediated by its glycosaminoglycan-binding region and not by CSVTCG
49. Identification of a receptor candidate for the carboxyl-terminal cell binding domain of thrombospondins
50. Thrombospondin modulates αvβ3 function through integrin-associated protein
51. Integrin-associated protein is a receptor for the C-terminal domain of thrombospondin
52. Integrin signaling
53. Sco-spondin: A new member of the thrombospondin family secreted by the subcommissural organ is a candidate in the modulation of neuronal aggregation
54. Identification of the low density lipoprotein receptor-related protein (LRP) as an endocytic receptor for thrombospondin-1
55. A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin
56. Membrane glycoprotein CD36: A review of its roles in adherence, signal transduction, and transfusion medicine
57. Thrombospondin signaling of focal adhesion disassembly requires activation of phosphoinositide 3-kinase
58. Beta-D-xyloside induced modulations of glycosaminoglycans, proliferation, and cytoskeletal organization of rat liver myofibroblast-like cells (transformed fat storing cells)
59. Thrombospondin-1 expression in bladder cancer: Association with p53 alterations, tumor angiogenesis and tumor progression
60. Heparin- and sulfatide-binding peptides from the type I repeats of human thrombospondin promote melanoma cell adhesion
61. Heparin-binding peptides from the type I repeats of thrombospondin. Structural requirements for heparin binding and promotion of melanoma cell adhesion and chemotaxis
62. Antiproliferative and antitumor activities of D-reversed peptides derived from the second type 1 repeat of thrombospondin-1
63. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
64. Evidence for cAMP-dependent platelet ectoprotein kinase activity that phosphorylates platelet glycoprotein IV (CD36)
65. Integrin associated proteins
66. The virtonectin receptor and its associated CD47 molecule mediates proinflammatory cytokine synthesis in human monocytes by interaction with soluble CD23
67. Interactions of neural glycosaminoglycans and proteoglycans with protein ligands: Assessment of selectivity, heterogeneity and the participation of core proteins in binding
68. Increased adhesion of erythrocytes to components of the extracellular matrix: Isolation and characterization of a red blood cell lipid that binds thrombospondin and laminin
69. Translocation of the Csk homologous kinase (Chk/Hyl) controls activity of CD36-anchored Lyn tyrosine kinase in thrombin-stimulated platelets
70. 4)beta 1-1 Cer] and has a sequence homology with other proteins that bind sulfated glycoconjugates
71. Exposure of the cryptic Arg-Gly-Asp sequence in thrombospondin-1 by protein disulfide isomerase
72. Membrane glycoprotein IV (CD36) is physically associated with the Fyn, Lyn, and Yes protein-tyrosine kinases in human platelets
73. Expression of integrin-associated protein gene associated with memory formation in rats
74. Integrins: Versatility, modulation, and signaling in cell adhesion
75. Inhibition of angiogenesis by thrombospondin-1 is mediated by two independent regions within the type 1 repeats
76. Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1
77. Glycoprotein IV-independent adhesion of sickle red blood cells to immobilized thrombospondin under flow conditions
78. Role of thrombospondin-1-derived peptide, 4NIK, in FGF-2-induced angiogenisis
79. The interaction of thrombospondin with platelet glycoprotein GPIIb-IIIa
80. F-spondin: A gene expressed at high levels in the floor plate encodes a secreted protein that promotes neural cell adhesion and neurite extension
81. Identification of active peptide sequences in the carboxyl-terminal cell binding domain of human thrombospondin-1
82. Identification of a new cell adhesion motif in two homologous peptides from the COOH-terminal cell binding domain of human thrombospondin
83. Cell attachment activity of the carboxyl-terminal domain of human thrombospondin expressed in Escherichia coli
84. Identification of an alpha(3)beta(1) integrin recognition sequence in thrombospondin-1
85. Molecular cloning of a gene encoding a new type of metalloproteinase-disintegrin family protein with thrombospondin motifs as an inflammation associated gene
86. An integrin receptor on normal and thrombasthenic platelets that binds thrombospondin
87. Cooperative binding of calcium to thrombospondin
88. Thrombin and chymotrypsin interactions with thrombospondin
89. Cell attachment to thrombospondin: The role of arg-gly-asp, calcium and integrin receptors
90. CD36 peptides enhance or inhibit CD36-thrombospondin binding. A two-step process of ligand-receptor interaction
91. Role of thrombospondin in platelet aggregation
92. UNC-5, a transmembrane protein with immunoglobulin and thrombospondin type 1 domains, guides cell and pioneer axon migration in C. elegans
93. Molecular cloning of integrin-associated protein: An immunoglobulin family member with multiple membrane-spanning domains implicated in alpha v beta 3-dependent ligand binding
94. Decreased resistance to bacterial infection and granulocyte defects in IAP-deficient mice
95. Phosphatidylinositol 3-kinase and focal adhesion kinase are early signals in the growth factor-like responses to thrombospondin-1 seen in human vascular smooth muscle
96. Liver heparan sulfate structure. A novel molecular design
97. Control of smooth muscle cell growth by components of the extracellular matrix: Autocrine role for thrombospondin
98. Cell surface thrombospondin is functionally essential for vascular smooth muscle cell proliferation
99. Thrombospondin induces dimerization of membrane-bound, but not soluble CD36
100. TGF-beta signal transduction
101. CD47 ligation induces caspase-independent cell death in chronic lymphocytic leukemia
102. Binding and degradation of platelet thrombospondin by cultured fibroblasts
103. Decorin inhibits cell attachment to thrombospondin-1 by binding to a KKTR-dependent cell adhesive site present within the N-terminal domain of thrombospondin-1
104. Low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor mediates the cellular internalization and degradation of thrombospondin. A process facilitated by cell-surface proteoglycans
105. Calcium ion binding to thrombospondin-1
106. The physiology of thrombospondin
107. Latent transforming growth factor-beta: Structural features and mechanisms of activation
108. Activation of latent TGF-beta by thrombospondin-1: Mechanisms and physiology
109. Transforming growth factor-beta complexes with thrombospondin
110. Heparin-binding peptides from thrombospondins 1 and 2 contain focal adhesion-labilizing activity
111. Vitronectin and thrombospondin promote retinal neurite outgrowth: Developmental regulation and role of integrins
112. A novel brain-specific p53-target gene, BAI1, containing thrombospondin type 1 repeats inhibits experimental angiogenesis
113. Identification of an actin binding region and a protein kinase C phosphorylation site on human fascin
114. CD36 directly mediates cytoadherence of plasmodium falciparum parasitized erythrocytes
115. Interaction of recombinant procollagen and properdin modules of thrombospondin-1 with heparin and fibrinogen/fibrin
116. CD47 mediates post-adhesive events required for neutrophil migration across polarized intestinal epithelia
117. Thrombospondin-1 is a potent mitogen and chemoattractant for human vascular smooth muscle cells
118. A carboxyl terminal truncation mutant of CD36 is secreted and binds thrombospondin: Evidence for a single transmembrane domain
119. Integrins take partners: Cross-talk between integrins and other membrane receptors
120. Thrombospondin deposition in rat carotid artery injury
121. CD36 gene transfer confers capacity for phagocytosis of cells undergoing apoptosis
122. The activation sequence of thrombospondin-1 interacts with the latency-associated peptide to regulate activation of latent transforming growth factor-β
123. Immunolocalization of thrombospondin-1 in human atherosclerotic and restenotic arteries
124. The platelet glycoprotein thrombospondin binds specifically to sulfated glycolipids
125. Comparison of the specificities of laminin, thrombospondin, and von Willebrand factor for binding to sulfated glycolipids
126. Platelet thrombospondin mediates attachment and spreading of human melanoma cells
127. Interactions of thrombospondin with sulfated glycolipids and proteoglycans of human melanoma cells
128. Regulation of tumor growth and metastasis by thrombospondin-1
129. Thrombospondin cooperates with CD36 and the vitronectin receptor in macrophage recognition of neutrophils undergoing apoptosis
130. Cell-associated proteoheparan sulfate mediates binding and uptake of thrombospondin in cultured porcine vascular endothelial cells
131. Thrombospondin causes activation of latent transforming growth factor-beta secreted by endothelial cells by a novel mechanism
132. Thrombospondin binds and activates the small and large forms of latent transforming growth factor-β in a chemically defined system
133. Regulation of transforming growth factor-beta activation by discrete sequences of thrombospondin 1
134. Identification and analysis of discrete functional domains in the pro region of pre-pro-transforming growth factor beta 1
135. Protein tyrosine phosphorylation and the adhesive functions of platelets
136. Glycoprotein IV mediates thrombospondin-dependent platelet-monocyte and platelet-U937 cell adhesion
137. Sense and antisense cDNA transfection of CD36 (glycoprotein IV) in melanoma cells
138. Isolation of cDNAs from the Cri-du-chat critical region by direct screening of a chromosome 5-specific cDNA library
139. The fluid mosaic model of the structure of cell membranes
140. Cooperation between thrombospondin-1 type 1 repeat peptides and alpha(v)beta(3) integrin ligands to promote melanoma cell spreading and focal adhesion kinase phosphorylation
141. Stimulation of fibroblast growth factor receptor-1 occupancy and signaling by cell surface-associated syndecans and glypican
142. Human monocyte-derived macrophage phagocytosis of senescent eosinophils undergoing apoptosis. Mediation by alpha v beta 3/CD36/thrombospondin recognition mechanism and lack of phlogistic response
143. Overexpression of thrombospondin-1 decreases angiogenesis and inhibits the growth of human cutaneous squamous cell carcinomas
144. Disulfides modulate RGD-inhibitable cell adhesive activity of thrombospondin
145. CD36 is palmitoylated on both N- and C-terminal cytoplasmic tails
146. Alterations in tumour suppressor gene p53 correlate with inhibition of thrombospondin-1 gene expression in colon cancer cells
147. Peptides derived from two separate domains of the matrix protein thrombospondin-1 have anti-angiogenic activity
148. Identification and characterization of a tumor cell receptor for CSVTCG, a thrombospondin adhesive domain
149. METH-1, a human ortholog of ADAMTS-1, and METH-2 are members of a new family of proteins with angio-inhibitory activity
150. Perlecan is responsible for thrombospondin 1 binding on the cell surface of cultured porcine endothelial cells
151. Modulation of endothelial cell proliferation, adhesion, and motility by recombinant heparin-binding domain and synthetic peptides from the type I repeats of thrombospondin
152. Sequential development of an angiogenic phenotype by human fibroblasts progressing to tumorigenicity
153. Transforming growth factor beta: The good, the bad, and the ugly
154. The thrombospondin receptor CD47 (IAP) modulates and associates with alpha2 beta1 integrin in vascular smooth muscle cells
155. Integrin-associated protein stimulates α2β1-dependent chemotaxis via Gi-mediated inhibition of adenylate cyclase and extracellular-regulated kinases
156. Transfection of thrombospondin 1 complementary DNA into a human breast carcinoma cell line reduces primary tumor growth, metastatic potential and angiogenesis
157. Ras N17 transfection inhibits thrombospondin-1-induced vascular smooth muscle cell migration
158. Beta 1 integrin- and proteoglycan-mediated stimulation of T lymphoma cell adhesion and mitogen-activated protein kinase signaling by thrombospondin-1 and thrombospondin-1 peptides
159. Interactions between thrombospondin and the small proteoglycan decorin: Interference with cell attachment
160. Human carcinoma cells bind thrombospondin through a Mr 80,000/105,000 receptor
161. Activated T-cell adhesion to thrombospondin is mediated by the alpha 4 beta 1 (VLA-4) and alpha 5 beta 1 (VLA-5) integrins
162. Thrombospondin mediates migration and potentiates platelet-derived growth factor-dependent migration of calf pulmonary artery smooth muscle cells
163. Phosphorylation of human fascin inhibits its actin binding and bundling activities
164. Activation of rat alveolar macrophage-derived latent transforming growth factor beta-1 by plasmin requires interaction with thrombospondin-1 and its cell surface receptor, CD36
165. The malaria circumsporozoite protein: Interaction of the conserved regions I and II-plus with heparin-like oligosaccharides in heparan sulfate
166. Specificities of heparin-binding sites from the amino-terminus and type 1 repeats of thrombospondin-1
167. Blocking ligand occupancy of the alphaVbeta3 integrin inhibits insulin-like growth factor I signaling in vascular smooth muscle cells